Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073528
Status:
COMPLETED
Last Update Posted:
2021-02-24
First Post:
2003-11-24
Brief Title:
Study Comparing Lapatinib GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Neoplasms |
Keywords:
| Name | View |
|---|---|
| ER | View |
| Lapatinib | View |
| Letrozole | View |
| breast carcinoma | View |
| breast cancer | View |
| breast lump | View |
| HER2 positive metastatic breast cancer | View |
| breast cancer positive for human epidermal growth factor receptor 2 | View |
| HER2 | View |
| breast cancer progression | View |
| estrogen-receptor positive breast cancer | View |